From biology to breakthroughs: new frontiers in head and neck cancer immunotherapy

In this week’s VJOncology podcast, we bring you key developments in novel approaches in immunotherapy refractory head and neck cancer. Join head and neck cancer expert Amanda Psyrri, MD, PhD, FACP, National Kapodistrian University of Athens, Athens, Greece, as she discusses on mechanisms of resistance to checkpoint inhibitors, strategies to overcome resistance such as antibody drug conjugates (ADCs) and tumor vaccines, as well as the trials assessing anti-TIGIT inhibitors.